Annandale Capital »

Aptose Biosciences shares owned by Annandale Capital

Quarter-by-quarter ownership of Aptose Biosciences (APTO) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Aptose Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aptose Biosciences held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptose Biosciences by Annandale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $11k 27k 0.41

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Put Put Option
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Iboxx Hi Yd Etf Put Option
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Global X Fds Glb X Mlp Enrg I (MLPX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Energy Transfer Com Ut Ltd Ptn (ET)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Annandale Capital

Top funds holding Aptose Biosciences

Armistice Capital
DRW Holdings
Sigma Planning
Nantahala Capital Management
Morgan Stanley
Annandale Capital
Cetera Investment Advisers
Texas Capital Bank Wealth Management Services
PDS Planning
Us Bancorp
Royal Bank of Canada
Gleason Group
Newbridge Financial Services Group
TD Waterhouse Canada
Advisor Group Holdings

View all funds holding Aptose Biosciences